Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer. - Wikidata - awgldk - TriplyDB

Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.

Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.

http://www.wikidata.org/entity/Q37520516

about

Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer.Landscape of somatic mutations in gastric cancer assessed using next-generation sequencing analysis

P2860

Q33760811-33B29656-B45C-4809-AF4B-CB3D92E563A1 Q58772571-6BB6C4D3-C85B-4984-9654-E1A492C1F72C

P2860

Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.

http://www.wikidata.org/entity/Q37520516

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Mutation spectrum of TP53 gene ...... nd survival of gastric cancer.

@en

Mutation spectrum of TP53 gene ...... nd survival of gastric cancer.

@nl

type

label

Mutation spectrum of TP53 gene ...... nd survival of gastric cancer.

@en

Mutation spectrum of TP53 gene ...... nd survival of gastric cancer.

@nl

prefLabel

Mutation spectrum of TP53 gene ...... nd survival of gastric cancer.

@en

Mutation spectrum of TP53 gene ...... nd survival of gastric cancer.

@nl

P1433

Q37520516-DF0DB759-0793-44B2-8CB2-725CF79D044D

P1476

Q37520516-DB2CC2BB-D86E-41A5-BE27-3E6C62126007

P2093

Q37520516-0A7A56CA-4C79-45DA-8306-1E9FAEB2E742

Q37520516-4013B3CD-E370-4547-A794-463E4EB99E21

Q37520516-5A395DD8-A78D-4F92-A0FF-15F54CEC6074

Q37520516-690BF5A7-0210-49BC-8DF8-28E07E21FB18

Q37520516-ACEA5A81-BC15-42DC-8AFF-7D3856D29785

Q37520516-B1A22C59-B759-4E6B-8B3D-7B354D8536A4

Q37520516-B687554E-9A6C-4356-BBBC-862BE53CC2E0

Q37520516-B7C1334A-655C-45DA-8AAE-2525033B5D68

Q37520516-B8798F16-8CB8-49D8-88B6-9083A5BA1F12

Q37520516-B9880129-7042-4CAD-B14A-4D4F60B582E4

P2860

Q37520516-1FB2E659-9B55-4303-B8EF-47FB085F9E9A

Q37520516-318474C2-78AD-405F-8F61-FFDC5855AF3A

Q37520516-46D1A0BC-A033-4E9A-BC64-04F3AA7FF7E5

Q37520516-4E86C284-EFCF-4098-9ACA-908D412F9290

Q37520516-676205AB-DCA9-4767-8ABD-DF76BF3917D4

Q37520516-6766522A-B878-4C1C-97D4-C9FCFBE22AFC

Q37520516-691D1FB4-0D91-4D51-A87F-E57F247EF9A2

Q37520516-6F10ED8A-BD8F-45CA-861A-7E7BE7605E37

Q37520516-8E59B666-E52E-4ACB-98A2-DA784EA9C2A8

Q37520516-8F6F1EDB-2063-4536-A47F-5019D02981AA

P304

Q37520516-1641A3DD-66B6-4C8D-BD61-1B6F0DF7E6E5

P31

Q37520516-DF360DC2-1000-4779-BBA7-9E9AD5400E1D

P356

Q37520516-1C443014-EF25-4256-B4FB-0A21972DAEDA

P407

Q37520516-9FC2C204-0B92-4327-8AC8-1B5AED0D45CA

P433

Q37520516-68496EC8-89AB-4D49-BAEF-B4A0BA484876

P478

Q37520516-957FFE1C-C751-4985-9C01-D7868DC0F80E

P577

Q37520516-FFF85C05-C9A0-46B4-A203-6F4E7EEFDC25

P698

Q37520516-4C89C59F-86A9-4DB5-ACE3-0F1AE31F73C0

P932

Q37520516-C2C4B1C3-741F-4133-B326-612EED970D77

P356

ONCOTARGET.9770

P1433

P1476

Mutation spectrum of TP53 gene ...... nd survival of gastric cancer.

@en

P2093

Jumpei Yamazaki

http://www.w3.org/2001/XMLSchema#string

Masaaki Okubo

http://www.w3.org/2001/XMLSchema#string

Mitsuo Nagasaka

http://www.w3.org/2001/XMLSchema#string

Naoki Ohmiya

http://www.w3.org/2001/XMLSchema#string

Naoko Nakano

http://www.w3.org/2001/XMLSchema#string

Noriyuki Horiguchi

http://www.w3.org/2001/XMLSchema#string

Takamitsu Ishizuka

http://www.w3.org/2001/XMLSchema#string

Tomohiko Kawamura

http://www.w3.org/2001/XMLSchema#string

Tomomitsu Tahara

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Shibata

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations of PIK3CA in gastric adenocarcinoma

Relationship between p53 status and response to chemotherapy in patients with gastric cancer: a meta-analysis

Comprehensive molecular characterization of gastric adenocarcinoma

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

Blinded by the Light: The Growing Complexity of p53

Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.

DNA damage and mutation in human cells exposed to nitric oxide in vitro.

DNA deaminating ability and genotoxicity of nitric oxide and its progenitors.

TP53 and gastric carcinoma: a review.

Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.

P304

42252-42260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.9770

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27323394

http://www.w3.org/2001/XMLSchema#string

P932

5173132

http://www.w3.org/2001/XMLSchema#string